Clinical trial · Observational
Assessment of Burden Disease in Patients With Mast Cell Disorders
Assessment of Personal, Psychosocial, Work, and Economic Burden in Patients With Mast Cell Disorders,
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The symptoms caused by mast cell disorders can have a significant impact on the state of health of individuals, constituting a real burden for them, and consequently altering their quality of life. It therefore seems important to clarify the impact on the quality of life, on the psycho-affective sphere, on professional life and on the direct and indirect costs caused by the disease, as well as on the "patient's remaining burden". It seems possible by a longitudinal study (patient follow-up over 1 year). Primary objective is Assessment of quality of life in adult patient with mast cell diseases at M0.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cutaneous | — | UNRESOLVED | — |
| Mastocytosis | Mastocytosis | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Score SMI | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- face-to-face patients
- description
- During this visit, the investigator will complete the SMI score.
- interventionNames
- Behavioral: Score SMI
- label
- Email patients
- description
- this visit at M0 + 7d will correspond to the emailing of the Mc\_QoL and Burden\_MCD questionnaires completed by the patient.
Primary outcomes (1)
- measure
- Quality of life of mast cell disorder patients
- timeFrame
- Baseline
- description
- Quality of life is evaluated with the WHOQOL-bref questionary. This validated questionnaire in French assesses six dimensions of quality of life.
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Months
- Maximum age
- 65 Months
Show eligibility criteria text
Inclusion Criteria: * Adult patient (\> 18 years old) with confirmed mast cell disorder according to international criteria * Patient affiliated to social security regime Exclusion Criteria: * Patient under legal protection (guardianship, curators or court order) * Patient does not speak French
References
Publications (0)
Data not yet available